4//SEC Filing
Humeau Laurent 4
Accession 0001055726-24-000030
CIK 0001055726other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:08 PM ET
Size
9.3 KB
Accession
0001055726-24-000030
Insider Transaction Report
Form 4
Humeau Laurent
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-15+4,771→ 26,040 total - Tax Payment
Common Stock
2024-05-15$13.07/sh−1,703$22,258→ 24,337 total - Exercise/Conversion
Restricted Stock Unit
2024-05-15−4,771→ 9,542 total→ Common Stock (4,771 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
- [F3]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001770390
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:08 PM ET
- Size
- 9.3 KB